Povorcitinib matching placebo. clinical trials

Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy, and Safety Study of Povorcitinib in Participants With Chronic Spontaneous Urticaria

This study is testing a new medicine, Povorcitinib, for people with chronic spontaneous urticaria (CSU), also known as chronic hives. It aims to see if the drug helps reduce itching and hives and if it's safe, compared to a dummy pill.